Dr. Khanna appreciates Dr. Paulus’ selfless approach: “He’s a very thoughtful, soft-spoken gentleman. He doesn’t say much at meetings, but when he does, he hits the nail on the head.” Dr. Furst seconds that impression. Dr. Paulus, he notes, “is the person who will sit in the background saying nothing. But when he speaks, everybody will listen, because he changes the whole tone or direction of the discussion.”
The guidance also comes in the form of written commentary. Former fellows and current colleagues alike remarked about the ubiquitous “red pen.” “You can depend, whenever you send something to him for review, that it will be covered in little red writing,” laughs Dr. Furst.
“Dr. Paulus always looks to create the strongest research product,” says Dr. Ranganath. She, too, is familiar with the red pen, and says, “It only shows love!”
References
- Paulus HE, Machleder H, Bangert R, et al. A case report: Thoracic duct lymphocyte drainage in rheumatoid arthritis. Clinical Immunol Immunopathol. 1973;1:173-181.
- Paulus HE, Machleder H, Levine S, et al. Lymphocyte involvement in rheumatoid arthritis. Arthritis Rheum. 1977;20:1249-1262.
- Paulus HE and Whitehouse MW. Drugs for chronic inflammatory disease. In: Rubin AA, Ed. Search for New Drugs. New York: Dekker; 1971:1-114.
- FDA Ad Hoc Advisory Committee. Non-steroidal, anti-inflammatory drug clinical testing guideline, working draft. Drug Research Reports. 1971;14.
- Paulus HE, Egger MJ, Ward JR, et al. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum. 1990;33: 477-484.
- Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552-1563.
- Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727-735.
- Ranganath VK, Yoon J, Khanna D, et al. Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis. 2007;66:1633-1640.
Editor’s note: Originally published November 2010
